A Phase I Clinical Study of GLR2037 in Patients With Advanced Prostate Cancer
ConditionProstate Cancer
Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexMale
Age18+
SponsorGan & Lee Pharmaceuticals.
About this trial
A Phase I Clinical Study of GLR2037 in Patients with Advanced Prostate Cancer
Eligibility criteria
Qualifiers
Male, aged ≥ 18 years.
Histologically or cytologically confirmed adenocarcinoma of the prostate, without neuroendocrine or small cell features.
Metastatic bone or soft tissue lesions documented by imaging.
Prior surgical or medical castration.
Disqualifiers
None
Trial design
Treatments tested in this trial
- GLR2037
Treatment groups
65 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov